Is the periodic repetition of a coagulation check necessary during anti-hepatitis C virus therapy?
Capra
F
F
Nicolini
N
N
Franchini
M
M
D001778:Blood Coagulation Disorders / Q000139:chemically induced*; D001780:Blood Coagulation Tests; D005169:Factor VIII / Q000037:antagonists & inhibitors; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000009:adverse effects*; D011994:Recombinant Proteins
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D005169:Factor VIII; C100416:peginterferon alfa-2a